Cynosure Management, LLC Axsome Therapeutics, Inc. Transaction History
Cynosure Management, LLC
- $648 Million
- Q4 2024
A detailed history of Cynosure Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Cynosure Management, LLC holds 6,547 shares of AXSM stock, worth $858,639. This represents 0.09% of its overall portfolio holdings.
Number of Shares
6,547
Previous 7,930
17.44%
Holding current value
$858,639
Previous $712,000
22.33%
% of portfolio
0.09%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding AXSM
# of Institutions
348Shares Held
36.2MCall Options Held
1.32MPut Options Held
1M-
Rtw Investments, LP New York, NY4.05MShares$531 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$512 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$433 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$193 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$182 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.62B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...